DANIEL R. OMSTEAD, ENG.SCD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

abrdn Healthcare Investors

Filing Date Source Excerpt
2003-05-12 DANIEL R. OMSTEAD, ENGSCD (49), Trustee (since 2003) of HQH and of HQL; President (since 2001) of HQH and HQL; President and Chief Executive Officer (since 2001) and Managing Director (since 2000) of the Adviser; formerly President and Chief Executive Officer (from 1997-2000) and Chief Operating Officer (1997) of Reprogenesis, Inc.

Data sourced from SEC filings. Last updated: 2025-12-06